• STRATA Skin Sciences to Participate at Upcoming Investor Conferences

    Source: Nasdaq GlobeNewswire / 06 Oct 2022 16:05:00   America/New_York

    HORSHAM, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will present at the Midcap Rodeo: Windy City Roundup 2022 and the LD Micro Main Event XV.

    Microcap Rodeo: Windy City Roundup 2022
    Date: Wednesday, October 12, 2022
    Time: 3:00 PM CDT
    For more information, please visit the events webpage, here.

    LD Micro Main Event XV
    Date: Wednesday, October 26, 2022
    Time: 12:30 PM PDT
    Virtual Viewers: Livestream

    About STRATA Skin Sciences, Inc.
    STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the in-office treatment of dermatologic conditions. Its products include the XTRAC®, XTRAC Momentum™ 1.0 and Pharos® excimer lasers, VTRAC® lamp systems, and TheraClear® treatment systems utilized in the treatment of psoriasis, vitiligo, acne and various other skin conditions.

    The Company’s proprietary XTRAC® and XTRAC Momentum™ 1.0 excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. In addition, STRATA's TheraClear®X, utilizes FDA-Cleared technology to address the estimated $5.5 billion market opportunity for acne treatment with a non-invasive, highly effective, in-office procedure.

    STRATA’s unique business model, in the U.S., leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.

    Investor Contact:
    Rich Cockrell
    CG Capital
    Phone: +1 (404) 736-3838
    Email: sskn@cg.capital


    Primary Logo

Share on,